5Braun J. Therapy for ankylosing spondylitis: new therapeutic modalities. Best Pract Res Clin Rheumatol, 2002,16(4):631
6Huang F, Gu J, Zhao W et al. One-year open-label trial of thalidomide in ankylosing spondylitis. Arthritis Rheum (Arthritis Care Res), 2002,47(3):249
7Baeten D, Van Damme N, Van den Bosch F et al. Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNF-α. Ann Rheum Dis, 2001,60(8):750
8Zou JX, Rudwaleit M, Thiel A et al. Down-regulation of the non-specific and antigen-specific T cell cytokine response in ankylosing spondylitis after treatment with Infliximab. Arthritis Rheum, 2001, 44(9s):S236
9Braun J, Brandt J, Listing J et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial. Lancet, 2002,359:1187
10Gorman J, Sack K, Davis J. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med, 2002, 346(18) :1349
